Newsletter

127120 - JS Link

127120 Summary
Biopharma
Stock Price & Overview
₩33,600 +3,700 (+12.37%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩33,600  ≈ US$24  ·  Market cap ₩1.2tn (≈ $879m)
Why this page exists. Korean issuers file to DART, not the SEC, and almost nothing is published in English. Titles here are translated; where kstock has read the filing, the row carries the explanation and the amount in won and dollars. How we pick »

127120 DART Filings

DART

Acquisition of Shares in Another Company

M&A08/31/26title translated
DART

Stock options exercised

Filing08/25/26title translated
DART

Repurchase of its own convertible bonds before maturity

Filing08/24/26title translated
DART

Half-Year Report

Periodic08/14/26title translated
DART

Securities issuance result (voluntary)

Filing07/29/26title translated
DART

Material event report (paid-in capital increase)

Filing07/21/26title translated
DART

Material event report (paid-in capital increase)

Filing07/15/26title translated
DART

Material event report (paid-in capital increase)

Filing07/07/26title translated
DART

Material event report (convertible bond issuance)

Filing06/26/26title translated
DART

Securities issuance result (voluntary)

Filing06/25/26title translated
DART

Securities issuance result (voluntary)

Filing06/25/26title translated
DART

Material event report (convertible bond issuance) ×2

Filing06/23/26title translated
DART

Material event report (convertible bond issuance) ×2

Filing06/17/26title translated
DART

Material event report (convertible bond issuance) ×2

Filing06/10/26title translated
DART

Quarterly Report

Periodic05/15/26title translated
DART

Single Supply Contract Signed

Contract05/13/26title translated
DART

Material event report (convertible bond issuance) ×2

Filing05/13/26title translated
DART

Acquisition of Shares in Another Company

M&A05/07/26title translated
10 routine filings (insider holdings reports, IR schedules)DART

Insider / Major Shareholder Holdings Report

Ownership08/31/26title translated
DART

5% Ownership Report — Large Holdings

Ownership08/04/26title translated
DART

5% Ownership Report — Large Holdings

Ownership08/03/26title translated
DART

5% Ownership Report — Large Holdings

Ownership07/31/26title translated
DART

5% Ownership Report — Large Holdings

Ownership07/30/26title translated
DART

Investor Relations Event

IR07/07/26title translated
DART

5% Ownership Report — Short Form

Ownership07/01/26title translated
DART

5% Ownership Report — Large Holdings

Ownership06/29/26title translated
DART

Insider / Major Shareholder Holdings Report

Ownership06/29/26title translated
DART

Investor Relations Event

IR06/11/26title translated
28 filings on file, grouped where one event produced many. Source: DART, operated by Korea's Financial Supervisory Service.

Similar to 127120

SymbolLast Price
007390Naturecell Co., Ltd.₩23,950
+0.2%
006280GC Biopharma Corp.₩127,600
+0.5%
950160Kolon Tissue Gene, Inc.₩17,100
+1.1%
039200Oscotec, Inc.₩36,600
+1.9%
069620Daewoong Pharma₩116,100
+1.1%
290650L & C BIO Co., Ltd.₩47,900
-1.4%
475830Orum Therapeutics, Inc.₩55,900
+2.6%
195940HK inno.N Corporation₩42,050
+0.7%
003090Daewoong Co., Ltd.₩16,860
-2.0%
086450Dong Kook Pharmaceutical Co., Ltd.₩21,600
-0.9%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.